Valuation: AngioDynamics, Inc.

Market Cap 648M 566M 532M 485M 911M 61.92B 911M 6.38B 2.46B 31.62B 2.43B 2.38B 102B P/E 2027 *
-29.8x
P/E 2028 * -53.4x
Enterprise Value 648M 566M 532M 485M 911M 61.92B 911M 6.38B 2.46B 31.62B 2.43B 2.38B 102B EV / Sales 2027 *
1.92x
EV / Sales 2028 * 1.82x
Free-Float
86.06%
Yield 2027 *
-
Yield 2028 * -
1 day+1.62%
1 week-0.06%
Current month-2.85%
1 month-0.51%
3 months+26.47%
6 months+50.53%
Current year+22.04%
1 week 14.97
Extreme 14.97
15.73
1 month 14.85
Extreme 14.85
16.29
Current year 9.39
Extreme 9.39
16.29
1 year 9.39
Extreme 9.39
16.29
3 years 5.26
Extreme 5.26
16.29
5 years 5.26
Extreme 5.26
32
10 years 5.26
Extreme 5.26
32
Manager TitleAgeSince
Chief Executive Officer 62 2016-03-31
Director of Finance/CFO 51 2019-10-22
Chief Tech/Sci/R&D Officer - 2016-12-31
Director TitleAgeSince
Chairman 65 2014-04-28
Director/Board Member 67 2007-01-28
Director/Board Member 62 2016-03-31
Date Insider Type Main position Quantity % Market Cap. Importance
7/30/26 Sell

General Counsel

-23,370 0.0565%
7/22/26 Exercice

Executive/Senior Manager

40,889 0.0990%
7/22/26 Exercice

General Counsel

27,417 0.0664%
Change 5-day change 1-year change 3-year change Capi.($)
+1.62%-0.06%+46.04%+123.22% 648M
+0.69%+1.63%-24.10%+5.64% 179B
-1.07%-3.18%-4.07%+13.08% 116B
-0.65%-2.74%+8.88%+69.09% 60B
+1.27%-1.57%-1.90%-31.00% 49.85B
-0.22%+1.23%+7.80%+45.79% 48.05B
+0.40%+3.56%+28.80%+2.32% 33.79B
+7.73%+7.23% - - 30.21B
+2.57%+1.67%+47.13%-0.38% 26.12B
+2.38%+8.63%+11.66%-10.18% 22.98B
Average +1.47%+1.50%+13.36%+24.18% 56.72B
Weighted average by Cap. +0.68%+0.44%-2.76%+13.50%

Financials

2027 *2028 *
Net sales 337M 295M 277M 253M 475M 32.25B 475M 3.33B 1.28B 16.47B 1.27B 1.24B 53.09B 355M 310M 292M 266M 500M 33.95B 500M 3.5B 1.35B 17.34B 1.33B 1.3B 55.9B
Net income -22.3M -19.49M -18.32M -16.71M -31.37M -2.13B -31.38M -220M -84.82M -1.09B -83.75M -81.91M -3.51B -12.67M -11.07M -10.4M -9.49M -17.82M -1.21B -17.82M -125M -48.18M -618M -47.57M -46.53M -1.99B
Net Debt - -
Logo AngioDynamics, Inc.
AngioDynamics, Inc. is a transformative medical technology company. The Company is focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options and improving quality of life for patients. It designs, manufactures, and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Its devices are generally used in minimally invasive, image-guided procedures. Its segments include Med Tech and Med Device. The Med Tech segment is comprised of its technology portfolio including Auryon, the thrombus management platform and NanoKnife. The Med Device segment includes its Core, Venous, Ports and other Oncology products. Its product types are Ablation, Catheters, Medical Balloons, and Ports. The Catheter products include Angiographic Catheters, Uni-Fuse Infusion Catheter and Drainage Catheters.
Employees
632
Date Price Change Volume
26-09-22 US$15.67 +1.62% 439,370
26-09-21 US$15.42 -0.13% 315,683
26-09-18 US$15.44 +0.46% 1,012,597
26-09-17 US$15.37 -0.58% 558,681
26-09-16 US$15.46 -1.40% 469,643
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
15.67USD
Average target price
20.00USD
Spread / Average Target
+27.63%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ANGO Stock
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!